...
首页> 外文期刊>Journal of International Medical Research >Prognostic Value of Protease-Activated Receptor 2 Expression in Oesophageal Squamous Cell Carcinoma
【24h】

Prognostic Value of Protease-Activated Receptor 2 Expression in Oesophageal Squamous Cell Carcinoma

机译:蛋白酶激活受体2表达在食管鳞状细胞癌中的预后价值。

获取原文

摘要

Protease-activated receptor-2 (PAR-2) is essential for the initiation and development of tumours, suggesting that the detection of PAR-2 expression might serve as a clinical marker in the prediction or diagnosis of clinical outcomes of malignant neoplasia. Using immunohisto chemical methods, this study investigated whether the detection of PAR-2 protein had clinical implications for patients with oesophageal squamous cell carcinoma (OSCC). PAR-2 protein was present at a high level in primary OSCC sites but at a low level in normal oesophageal tissue. The level of PAR-2 protein in tumours was significantly correlated with the clinical stage and histological grade of disease. Patients with tumours highly positive for PAR-2 protein had a significantly worse prognosis than those with lower PAR-2 levels. Thus, the over-expression of PAR-2 is a characteristic feature of OSCC and suggests that the immuno histochemical detection of raised levels of PAR-2 may be a potentially useful prognostic indicator.
机译:蛋白酶激活受体2(PAR-2)对肿瘤的发生和发展至关重要,这表明PAR-2表达的检测可作为预测或诊断恶性肿瘤的临床结果的临床标志。使用免疫组织化学方法,本研究调查了PAR-2蛋白的检测是否对食道鳞状细胞癌(OSCC)患者具有临床意义。 PAR-2蛋白在原发性OSCC位点高水平存在,但在正常食管组织中低水平存在。肿瘤中PAR-2蛋白的水平与疾病的临床分期和组织学等级显着相关。 PAR-2蛋白高度阳性的肿瘤患者的预后明显低于PAR-2水平较低的患者。因此,PAR-2的过表达是OSCC的一个特征,提示PAR-2升高水平的免疫组织化学检测可能是有用的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号